Ultragenyx Pharmaceutical Inc.

Q2 2023 13F Holders

Symbol
RARE
CUSIP
90400D108
Type
Equity
Class
COM
Num filers
245
Total reported value, excl. options
$3.21B
Manager Report Date Value ($000) Shares